Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-demecolcine | decreases expression | EXP | | 6480464 | Demecolcine results in decreased expression of NRN1 mRNA | CTD | PMID:23649840 | (S)-nicotine | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Nicotine results in decreased expression of NRN1 mRNA | CTD | PMID:21955143 | 1,2-dimethylhydrazine | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA] | CTD | PMID:22206623 | 1,2-dimethylhydrazine | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA | CTD | PMID:22206623 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NRN1 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of NRN1 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nrn1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NRN1 mRNA | CTD | PMID:21570461 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA | CTD | PMID:28628672 | 3-methylcholanthrene | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Methylcholanthrene results in increased expression of NRN1 mRNA | CTD | PMID:20713471 | 4,4'-sulfonyldiphenol | decreases methylation | ISO | Nrn1 (Mus musculus) | 6480464 | bisphenol S results in decreased methylation of NRN1 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | affects methylation | ISO | Nrn1 (Mus musculus) | 6480464 | bisphenol S affects the methylation of NRN1 gene | CTD | PMID:31683443 | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of NRN1 gene | CTD | PMID:31601247 | 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of NRN1 mRNA | CTD | PMID:19194470 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of NRN1 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of NRN1 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NRN1 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of NRN1 mRNA | CTD | PMID:33167477 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of NRN1 mRNA | CTD | PMID:24449571 | arsane | increases response to substance | EXP | | 6480464 | NRN1 mRNA results in increased susceptibility to Arsenic | CTD | PMID:17976673 | arsenic atom | increases response to substance | EXP | | 6480464 | NRN1 mRNA results in increased susceptibility to Arsenic | CTD | PMID:17976673 | arsenite(3-) | increases methylation | EXP | | 6480464 | arsenite results in increased methylation of NRN1 promoter | CTD | PMID:23974009 | benzo[a]pyrene | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of NRN1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of NRN1 3' UTR | CTD | PMID:27901495 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NRN1 5' UTR and Benzo(a)pyrene affects the methylation of NRN1 promoter | CTD | PMID:27901495 | Benzo[ghi]perylene | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | 1 and 12-benzoperylene results in decreased expression of NRN1 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of NRN1 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA | CTD | PMID:28628672 | bisphenol A | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of NRN1 mRNA | CTD | PMID:25594700 | cadmium dichloride | affects expression | ISO | Nrn1 (Mus musculus) | 6480464 | Cadmium Chloride affects the expression of NRN1 mRNA | CTD | PMID:18974090 | carbon nanotube | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to NRN1 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Chlordecone results in increased expression of NRN1 mRNA | CTD | PMID:33711761 | cocaine | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Cocaine results in decreased expression of NRN1 mRNA | CTD | PMID:18355967 | cocaine | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in decreased expression of NRN1 mRNA] | CTD | PMID:18355967 | cyclosporin A | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Cyclosporine results in decreased expression of NRN1 mRNA | CTD | PMID:19770486 | dexamethasone | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of NRN1 mRNA | CTD | PMID:22733784 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA | CTD | PMID:28628672 | dioxygen | multiple interactions | EXP | | 6480464 | 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1 more ... | CTD | PMID:24403227 | dioxygen | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of NRN1 mRNA | CTD | PMID:30529165 | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of NRN1 mRNA | CTD | PMID:24236059 and PMID:24403227 | disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of NRN1 mRNA | CTD | PMID:18175754 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA | CTD | PMID:27188386 | entinostat | decreases expression | EXP | | 6480464 | entinostat results in decreased expression of NRN1 mRNA | CTD | PMID:27188386 | ethanol | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Ethanol results in increased expression of NRN1 mRNA | CTD | PMID:21955143 | ethanol | affects splicing | ISO | Nrn1 (Mus musculus) | 6480464 | Ethanol affects the splicing of NRN1 mRNA | CTD | PMID:30319688 | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of NRN1 mRNA | CTD | PMID:23649840 | fluoxetine | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Fluoxetine results in increased expression of NRN1 mRNA | CTD | PMID:18301726 | folic acid | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | Folic Acid inhibits the reaction [1 and 2-Dimethylhydrazine results in decreased expression of NRN1 mRNA] | CTD | PMID:22206623 | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of NRN1 promoter | CTD | PMID:22847954 | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of NRN1 mRNA | CTD | PMID:23649840 | genistein | affects expression | ISO | Nrn1 (Mus musculus) | 6480464 | Genistein affects the expression of NRN1 mRNA | CTD | PMID:32186404 | gentamycin | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of NRN1 mRNA | CTD | PMID:33387578 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of NRN1 mRNA | CTD | PMID:28628672 | maneb | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of NRN1 mRNA | CTD | PMID:36117858 | methoxychlor | affects methylation | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of NRN1 gene | CTD | PMID:35440735 | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of NRN1 mRNA | CTD | PMID:23649840 | methylmercury chloride | increases expression | EXP | | 6480464 | methylmercuric chloride results in increased expression of NRN1 mRNA | CTD | PMID:34089799 | mono(2-ethylhexyl) phthalate | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | mono-(2-ethylhexyl)phthalate results in decreased expression of NRN1 mRNA | CTD | PMID:22401849 | morphine | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Morphine results in decreased expression of NRN1 mRNA | CTD | PMID:21955143 | N-methyl-4-phenylpyridinium | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of NRN1 mRNA | CTD | PMID:28801915 | N-nitrosodiethylamine | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of NRN1 mRNA | CTD | PMID:17942915 | N-nitrosodiethylamine | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of NRN1 mRNA] | CTD | PMID:17942915 | nicotine | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Nicotine results in decreased expression of NRN1 mRNA | CTD | PMID:21955143 | ozone | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Ozone results in decreased expression of NRN1 mRNA | CTD | PMID:17095637 | ozone | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NRN1 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of NRN1 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | Acetaminophen results in increased expression of NRN1 mRNA | CTD | PMID:29246445 | paracetamol | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of NRN1 mRNA | CTD | PMID:33387578 | paracetamol | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | PANX1 gene mutant form inhibits the reaction [Acetaminophen results in increased expression of NRN1 mRNA] | CTD | PMID:29246445 | paraquat | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | [Maneb co-treated with Paraquat] results in decreased expression of NRN1 mRNA | CTD | PMID:36117858 | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of NRN1 promoter | CTD | PMID:22847954 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Nrn1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of NRN1 mRNA | CTD | PMID:36331819 | pirinixic acid | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of NRN1 mRNA | CTD | PMID:23811191 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of NRN1 mRNA | CTD | PMID:22714537 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA | CTD | PMID:27188386 | sodium arsenite | affects methylation | EXP | | 6480464 | sodium arsenite affects the methylation of NRN1 gene | CTD | PMID:28589171 | sodium arsenite | increases expression | ISO | Nrn1 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of NRN1 mRNA | CTD | PMID:37682722 | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of NRN1 promoter | CTD | PMID:22847954 | Testosterone propionate | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Testosterone Propionate results in increased expression of NRN1 mRNA | CTD | PMID:19427307 | titanium dioxide | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of NRN1 mRNA | CTD | PMID:27760801 | trichloroethene | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of NRN1 mRNA | CTD | PMID:33387578 | trimellitic anhydride | decreases expression | ISO | Nrn1 (Mus musculus) | 6480464 | trimellitic anhydride results in decreased expression of NRN1 mRNA | CTD | PMID:19042947 | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of NRN1 mRNA | CTD | PMID:29024780 | undecane | increases expression | ISO | Nrn1 (Rattus norvegicus) | 6480464 | undecane results in increased expression of NRN1 protein | CTD | PMID:17337753 | valproic acid | multiple interactions | EXP | | 6480464 | CEBPA protein affects the reaction [Valproic Acid results in increased expression of NRN1 mRNA] | CTD | PMID:32623605 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of NRN1 mRNA | CTD | PMID:28001369 and PMID:32623605 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NRN1 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NRN1 mRNA | CTD | PMID:25979313 | vincristine | decreases expression | EXP | | 6480464 | Vincristine results in decreased expression of NRN1 mRNA | CTD | PMID:23649840 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of NRN1 mRNA | CTD | PMID:27188386 | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRN1 mRNA | CTD | PMID:27188386 | |